Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
Condition(s):Venous Thrombosis; Pulmonary EmbolismLast Updated:April 19, 2016Terminated
Hide Studies Not Open or Pending
Condition(s):Venous Thrombosis; Pulmonary EmbolismLast Updated:April 19, 2016Terminated
Condition(s):Liver Cirrhosis; Portal HypertensionLast Updated:January 8, 2019Unknown status
Condition(s):Venous ThromboembolismLast Updated:June 3, 2008Completed
Condition(s):Thromboembolism; HemodialysisLast Updated:September 10, 2014Completed
Condition(s):Acute Kidney Injury; Renal Replacement Therapy; AnticoagulantsLast Updated:November 22, 2023Recruiting
Condition(s):Colorectal Cancer Metastatic; ThromboembolismLast Updated:February 23, 2024Recruiting
Condition(s):Adenocarcinoma of the ColonLast Updated:May 17, 2021Completed
Condition(s):Epithelial Ovarian CancerLast Updated:January 25, 2024Recruiting
Condition(s):Acute Coronary SyndromeLast Updated:January 23, 2012Completed
Condition(s):Aortic Diseases; Arterial Disease; ThrombosisLast Updated:September 26, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.